Sunday, November 11, 2018

Thoughts for this Veterans Day

Today is Veterans Day (Armistice Day or Remembrance Day if you live outside the U.S.). This year, it marks the 100th anniversary of the end of World War I.

Once in awhile, I like to post something that's not about ET to remind us that, even though we have a chronic illness, we are still alive and still have the capacity to engage with the human condition, past and present. Maybe that's what we were put on this earth to do. 

So here are some thoughts on this special Veterans Day.

That's my grandfather, Corporal Clinton Foster, in the photo  at left. My grandmother, whom he would marry a few years later, dressed in her best summer whites, is standing at far left with his sisters. 

Grampa enlisted in 1917 and served Stateside during the war in the mailroom. 

His brother-in-law, my great-uncle Martin Keehn (his future wife, my Aunt Mary, is in the photo in the black hat at right), would be sent to France and serve out the war in a trench. Uncle Martin received a Purple Heart for wounds he received in battle. He would never speak of what he had seen.

Friday, November 9, 2018

Jakafi/lymphoma link?

Image result for jakafi lymphoma
Lymphoma News Today has a more about the Jakafi-
lymphoma link. 
Many of you have been hearing about a possible link between Jakafi (ruxolitinib) and an aggressive form of lymphoma. In two European studies of MPN patients, a significantly higher number of those those receiving Jakafi developed an aggressive form of lymphoma than those receiving another drug. This means that doctors should proceed with caution when prescribing this drug. 

Jakafi was first approved by the U.S. Food and Drug Administration for myelofibrosis patients in 2011. Jakafi was approved for polycythemia vera patients a few years later. It is not yet officially approved for use in ET patients, but some doctors prescribe it "off-list" if ET patients aren't responding to hydroxyurea or anagrelide (trade names Hydrea and Agrylin).